Extraordinary claims require extraordinary evidence
- 30 September 2005
- journal article
- editorial
- Published by Elsevier in Journal of Health Economics
- Vol. 24 (5) , 1030-1033
- https://doi.org/10.1016/j.jhealeco.2005.07.001
Abstract
No abstract availableThis publication has 3 references indexed in Scilit:
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Therapeutic-Class Wars -- Drug Promotion in a Competitive MarketplaceNew England Journal of Medicine, 1994
- Cost of innovation in the pharmaceutical industryJournal of Health Economics, 1991